Filing Details
- Accession Number:
- 0000014272-21-000226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-24 17:25:14
- Reporting Period:
- 2021-11-22
- Accepted Time:
- 2021-11-24 17:25:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1524143 | Paul Autenried Von | Bristol-Myers Squibb Company 430 E. 29Th Street, 14 Floor New York NY 10016 | Evp, Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2021-11-22 | 18,363 | $57.17 | 96,307 | No | 4 | S | Indirect | Trust |
Common Stock, $0.10 Par Value | Disposition | 2021-11-23 | 15,418 | $57.47 | 80,889 | No | 4 | S | Indirect | Trust |
Common Stock, $0.10 Par Value | Disposition | 2021-11-24 | 17,353 | $56.92 | 63,536 | No | 4 | S | Indirect | Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Trust |
No | 4 | S | Indirect | Trust |
No | 4 | S | Indirect | Trust |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $57.16 to $57.18, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Shares held in a Spousal Lifetime Access Trust (SLAT).
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $57.47 to $57.48, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $56.91 to $56.93, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.